FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

Katie Price has issued a warning to the public over the horrors of vaping in a candid social media post. The former glamour ...

Dr. Barnard explains how his research suggests that processed meat may negatively affect not only your heart health, but also ...

VANCOUVER, BC, Dec. 2, 2025 /CNW/ - BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and ...

To kick off National Influenza Vaccination Week (December 1 - 6), the American Heart Association®, American Lung Association®, American Diabetes Association® (ADA) and National Foundation for ...

Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev; Boehringer Ingelheim) suggest there is ...

Researching IPF after her late husband's diagnosis meant learning many new acronyms and abbreviations, says guest writer.

O KLAHOMA CITY ( KFOR) – An Oklahoma City woman was given a few years to live in 2022, after being diagnosed with a serious lung disease. However, thanks to a double lung transplant, she was given a ...

Nerandomilast, a PDE4 inhibitor, has shown significant efficacy in progressive pulmonary fibrosis (PPF), offering an ...

A metro woman was given a few years to live in 2022, after being diagnosed with a serious lung disease. However, thanks to a double lung transplant, she was given a second chance at life.

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

Inhaled lipid nanoparticles loaded with two medicines reduced IPF lung stiffness and fibrosis in mice, outperforming an ...